Bristol-Myers Squibb Company Announces Completion of ConvaTec Divestiture

August 1, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that Nordic Capital Fund VII and Avista Capital Partners have completed their acquisition of ConvaTec, a business unit of Bristol-Myers Squibb.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions

Bristol Myers Squibb Company